瘤向siRNA通过特定于腺素受体的curdlan纳米粒子传递
Qingming Bao1, Tsogzolmaa Ganbold1, Mingming Bao1
1Inner Mongolia Key Laboratory of Mongolian Medicinal Chemistry, School of Chemistry & Chemical Engineering, Inner Mongolia University, Hohhot, Inner Mongolia 010020, PR China.
International journal of biological macromolecules
|September 13, 2023
概括
化腺功能化氨基库德兰 (pAVC) 聚合物增强了核酸药物的生物相容性和瘤向性. 这些pAVC聚合物特别将siRNA传递给瘤,通过击倒STAT3.3来抑制生长.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 氨基化库德兰衍生物显示出作为核酸载体的潜力.
- 接体功能化兰衍生物通过受体介导内细胞分裂增强细胞特异性吸收.
- 提高生物相容性和瘤向性对于有效的核酸药物输送至关重要.
研究的目的:
- 开发基化腺功能化氨基库德兰 (pAVC) 聚合物,以提高生物相容性和瘤向性.
- 评估pAVC聚合物在输送核酸药物中的瘤向疗效和安全性.
- 为了确认pAVC聚合物的腺受体 (AR) 依赖的细胞吸收机制.
主要方法:
- 化腺功能化氨基库德兰 (pAVC) 聚合物的合成和表征.
- 在pAVC聚合物介导siRNA输送和瘤细胞中细胞毒性的体外评估.
- 在体内评估pAVC-siRNA纳米颗粒的瘤向效率和治疗效果.
- 使用特定抑制剂 (AMP,GMP) 确认腺受体 (AR) 的依赖性.
主要成果:
- pAVC聚合物表明瘤细胞吸收AR-依赖的siRNA,被AMP抑制.
- 与非化衍生物相比,pAVC聚合物表现出保存的受体识别和显著降低的细胞毒性.
- pAVC纳米颗粒在体内显示出显著的瘤向效率.
- 通过pAVC4聚合物 (最高PEG替代) 传递的siRNA专门针对瘤组织,导致STAT3敲击和瘤生长抑制.
结论:
- pAVC聚合物是一种有希望的,生物相容的载体系统,用于向的核酸药物输送.
- 开发的pAVC聚合物增强了siRNA的瘤特异性传递和治疗疗效.
- 这一策略为使用基于核酸的药物治疗癌症提供了潜在的进步.
更多相关视频
08:31Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
11.0K
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
10.7K
相关概念视频
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
